KMTS vs. LIVN, WRBY, NVCR, ENOV, EYE, LMAT, CNMD, AORT, CDRE, and ESTA
Should you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), Enovis (ENOV), National Vision (EYE), LeMaitre Vascular (LMAT), CONMED (CNMD), Artivion (AORT), Cadre (CDRE), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.
Kestra Medical Technologies vs. Its Competitors
LivaNova (NASDAQ:LIVN) and Kestra Medical Technologies (NASDAQ:KMTS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.
In the previous week, Kestra Medical Technologies had 2 more articles in the media than LivaNova. MarketBeat recorded 8 mentions for Kestra Medical Technologies and 6 mentions for LivaNova. LivaNova's average media sentiment score of 0.73 beat Kestra Medical Technologies' score of 0.26 indicating that LivaNova is being referred to more favorably in the media.
LivaNova has higher revenue and earnings than Kestra Medical Technologies.
Kestra Medical Technologies has a net margin of 0.00% compared to LivaNova's net margin of -17.41%. LivaNova's return on equity of 13.67% beat Kestra Medical Technologies' return on equity.
97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
LivaNova presently has a consensus target price of $59.29, indicating a potential upside of 36.51%. Kestra Medical Technologies has a consensus target price of $27.50, indicating a potential upside of 68.82%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than LivaNova.
Summary
LivaNova beats Kestra Medical Technologies on 9 of the 12 factors compared between the two stocks.
Get Kestra Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Kestra Medical Technologies Competitors List
Related Companies and Tools
This page (NASDAQ:KMTS) was last updated on 7/16/2025 by MarketBeat.com Staff
